Gyros platform integrated into second, US-based, contract research organization. Radix BioSolutions adopts Gyrolab xP workstation for immunoassay development.
Gyros platform enters leading US Clinical Research Organization. CEDRA Corporation, a division of Worldwide Clinical Trials, invests in Gyrolab workstation.